Recruiting NA Shoulder Arthropathy Associated With Other Conditions

New treatment option for Shoulder Arthropathy Associated With Other Conditions

Official title Reaching Motion During Functional Activities

ClinicalTrials.gov ID: NCT06162858

What this study is testing

What it's testing
Taking and moving objects is essential. When this becomes difficult, it affects daily functioning.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older. Healthy volunteers may be eligible.

You may be able to join if

  • 60 years and older
  • no shoulder pain + no diagnosis of shoulder problem
  • primary reverse shoulder arthroplasty

You likely can't join if

  • younger than 60 years
  • shoulder pain at moment of testing
  • known shoulder problem ( incl. diagnosis)

The study team makes the final eligibility decision.

Where it's taking place

  • Ghent, Belgium

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.